Corporate venture capital investment strategies in the COVID-19 pandemic

7 July 2020 | 11:30 - 12:30 ET
11:30 AM - 12:30 PM (UTC-05:00)

Click here for webinar recording

Venture capital has endured three major downturns in the last 30 years. While prior downturns have seen the creation of many successful companies, they have also introduced significant risks for CVCs' investments and reputation. Thank you for joining us for a panel discussion focused on what CVCs can learn from past downturns to navigate investing during the coronavirus disease 2019 (COVID-19) pandemic. Our esteemed panel members addressed these topics and others:

  • Why now can be a great time to invest
  • Strategies for managing your current portfolio
  • Preparing for new terms, such as a reverse to pay-to-play and anti-dilution provisions
  • Evaluating "bargains" for existing companies
  • Accessing the secondary market
  • VC ecosystem drivers
  • Reviewing opportunities for investment in new companies
  • How to avoid reputational risks


Paul Holland, Managing Director, Corporate Investing Practice, Mach49

Mark Radcliffe, Chair, Corporate Venture Capital Practice, DLA Piper

Nicolas Sauvage, Managing Director, TDK Ventures

Jacqueline LeSage Krause, Managing Director, Munich Re Ventures 

For more information

Please contact Ben Goodall with questions.